ask="27.750"
ask_size="200"
average_daily_volume="745558"
bid="26.500"
bid_size="100"
book_value="14.598"
change="+1.025"
change_from_200_day_moving_average="5.751"
change_from_50_day_moving_average="4.925"
change_from_52_week_high="-9.885"
change_From_52_week_low="11.075"
change_in_percent="+3.875%"
close="27.475"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.765"
ebitda="11.20M"
eps_estimate_current_year="1.130"
eps_estimate_next_quarter="0.280"
eps_estimate_next_year="1.700"
ex_dividend_date="N/A"
float_shares="36854000"
high="27.800"
high_52_weeks="37.360"
last_trade_date="3/1/2017"
last_trade_price="27.475"
last_trade_size="55575"
last_trade_time="4:00pm"
low="26.350"
low_52_weeks="16.400"
market_capitalization="1.25B"
moving_average_200_day="21.724"
moving_average_50_day="22.550"
name="Acorda Therapeutics
Inc."
notes="N/A"
one_year_target_price="33.100"
open="26.850"
pe_ratio="N/A"
peg_ratio="0.840"
percent_change_from_200_day_moving_average="+26.472%"
percent_change_from_50_day_moving_average="+21.840%"
percent_change_from_52_week_high="-26.459%"
percent_change_from_52_week_low="+67.530%"
previous_close="26.450"
price_eps_estimate_current_year="24.314"
price_eps_Estimate_next_year="16.162"
price_per_book="1.812"
price_per_sales="2.316"
revenue="519.60M"
shares_outstanding="45500000"
short_ratio="8.300"
stock_exchange="NMS"
symbol="ACOR"
volume="888682"
weeks_range_52="16.400 - 37.360"
